Health | Lenny Bernstein & Laurie McGinley, The Washington Post | Wednesday March 20, 2019
The drug will be available to patients only through a restricted distribution program at certified facilities - such as doctors' offices or clinics - where health care providers can carefully monitor the patient. It will carry a "boxed warning," which is the strongest warning required by the FDA.
www.ndtv.com